Clinical Trials Directory

Trials / Conditions / PIK3CA-related Overgrowth Spectrum

PIK3CA-related Overgrowth Spectrum

5 registered clinical trials studyying PIK3CA-related Overgrowth Spectrum — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
NCT05983159
Murdoch Childrens Research InstitutePhase 2
CompletedA Study of the Epidemiology and Hospital Management of Patients With PROS in France
NCT07222423
Novartis Pharmaceuticals—
CompletedNational Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
NCT05563831
Institut National de la Santé Et de la Recherche Médicale, France—
CompletedHealth-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spect
NCT05294289
Novartis Pharmaceuticals—
RecruitingStudy of Proteus Syndrome and Related Congenital Disorders
NCT00001403
National Human Genome Research Institute (NHGRI)—